No it is not. They already have what is equivalent to phase two studies showing efficacy and safety. Read what JC. Meredith writes. He doesn't waste his time posting anymore but knows the score. This compound will change medicine. They already know that and so do the largest shareholders. In fact, many more coming.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.